Placenta extract injection aims to tame liver disease
Disease control
Recruiting now
This phase 3 study tests a treatment called LAENNEC, made from human placenta, for people with chronic liver disease. It compares giving the drug through an IV drip versus a standard injection under the skin. The main goal is to see if the IV form lowers liver enzyme (ALT) levels…
Phase: PHASE3 • Sponsor: Green Cross Wellbeing • Aim: Disease control
Last updated May 06, 2026 16:03 UTC